Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a]anthracene
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 105 (3) , 434-442
- https://doi.org/10.1016/0041-008x(90)90147-m
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[a]anthracene: Dysfunction of antigen recognitionInternational Journal of Immunopharmacology, 1989
- Inhibition of IL-2 responsiveness following exposure to benzo(A)pyrene is due to alterations in accessory cell functionInternational Journal of Immunopharmacology, 1988
- Persistent suppression of humoral immunity produced by 7,12-dimethylbenz(a)anthracene (DMBA) in B6C3F1 mice: Correlation with changes in spleen cell surface markers detected by flow cytometryInternational Journal of Immunopharmacology, 1988
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- Effect of in vivo administration of the carcinogen benzo(a)pyrene on interleukin-2 and interleukin-3 productionInternational Journal of Immunopharmacology, 1987
- Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2International Journal of Immunopharmacology, 1987
- Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposureInternational Journal of Immunopharmacology, 1986
- Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistanceToxicology and Applied Pharmacology, 1984
- Natural host defence during oncogenesis. NK activity and dimethylbenzanthracene carcinogenesisInternational Journal of Cancer, 1983
- PGI2 and PGD2 effects on cyclic amp and human T-cell mitogenesisProstaglandins and Medicine, 1979